Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer
Status: Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 17 Dec 2019
Price : $35 *
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Therapeutic Use
- Acronyms RAD 1702
- 13 Dec 2019 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 29 May 2019 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2018 Biomarkers information updated